drugset / Trial / NCT06125782

Effect of Omega-3 Fatty Acid on Neurobehavioral Status of Children With Autism Spectrum Disorder: A Randomized, Double-Blind, Placebo Controlled Trial

NCT06125782

RandomizedFactorialTriple-blindTreatment

Summary

This study is conducted to assess whether Omega-3 fatty acid improves neurobehavioral staus of children with Autism Spectrum Disorder and whether there is any correlation of this improvement with reference range of Omega-3 fatty acid.

Timeline

Start
2023-09-19
Primary completion
2024-01-30
Completion
2024-02-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lovaza Other / unclassified 1 g